Consultation on Specialised Services clinical commissioning policies and service specifications
NHS England has today (22 February 2016) launched a 30 day public consultation on a number of proposed new products for specialised services, (including service specifications and clinical commissioning policies).
There has already been extensive engagement on these national specifications and policies. They have been developed with the support and input of lead clinicians and tested with stakeholders. This approach has helped ensure that the views of key stakeholders have informed and influenced the development of the specifications and policies to date.
Please note this is one of several public consultations on a proposed new draft products for specialised services. We now wish to test them further with wider stakeholders through public consultation.
3 comments
Wrong-:It will be 30 day Consultation from a few members of the public which will have been selected for their knowledge of what new products to obtain for specialised services. What your putting across is your democratically consulting all members of the public in decisions in the running of the NHS, which a nonsense more than likely the decisions have already taken place by the Department of Health by the cuts to the NHS Budget
While the links are to the correct documents on the following page https://www.engage.england.nhs.uk/consultation/clinical-commissioning-wave4 are correct, the descrptions are not e.g. pegvisomant -> dornase alfa, tolvaptan -> pasireotide etc
Hi Andrew,
Thank you for your comment and bringing this to our attention. I can confirm that the titles of the links have now been corrected.
Kind Regards
NHS England